For the quarter ended September 2026, MetLife (MET) reported revenue of $19.91 billion, up 11.2% over the same period last year. EPS came in at $2.85, compared to $2.34 in the year-ago quarter.
The reported revenue represents a surprise of -1.02% over the Zacks Consensus Estimate of $20.11 billion. With the consensus EPS estimate being $2.71, the EPS surprise was +5.17%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how MetLife performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Institutional Client AUM: $307.96 billion versus the three-analyst average estimate of $326.37 billion. Total AUM: $723.44 billion compared to the $753.76 billion average estimate based on three analysts. METLIFE INVESTMENT MANAGEMENT(MIM)-GA AUM: $415.48 billion compared to the $427.39 billion average estimate based on three analysts. Adjusted Revenue- Latin America- Universal life and investment-type product policy fees: $425 million versus the three-analyst average estimate of $403.99 million. The reported number represents a year-over-year change of +12.7%. Adjusted Revenue- EMEA- Net investment income: $73 million versus the three-analyst average estimate of $69.44 million. The reported number represents a year-over-year change of +9%. Adjusted Revenue- Latin America- Other Revenues: $-15 million versus the three-analyst average estimate of $-2.93 million. The reported number represents a year-over-year change of +650%. Adjusted Revenue- EMEA- Other Revenues: $12 million versus the three-analyst average estimate of $8.74 million. The reported number represents a year-over-year change of +71.4%. Revenue- Premiums: $11.82 billion versus the four-analyst average estimate of $12.11 billion. The reported number represents a year-over-year change of +12%. Revenue- Other Revenues: $853 million versus the four-analyst average estimate of $767.89 million. The reported number represents a year-over-year change of +17.8%. Revenue- Net investment income: $6.2 billion compared to the $5.89 billion average estimate based on four analysts. The reported number represents a change of +1.8% year over year. Revenue- Universal life and investment-type product policy fees: $1.39 billion compared to the $1.35 billion average estimate based on four analysts. The reported number represents a change of +11.1% year over year. Adjusted Revenue- Retirement & Income Solutions- Premiums: $1.82 billion versus the three-analyst average estimate of $2 billion. The reported number represents a year-over-year change of +74.5%.View all Key Company Metrics for MetLife here>>>
Shares of MetLife have returned +3.6% over the past month versus the Zacks S&P 500 composite's -2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This innovative software-as-a-service firm upped its user base +22% year over year. That rate is increasing and margins are expanding as AI efficiencies take effect. Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
MetLife, Inc. (MET): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).